Published in AIDS Weekly, December 4th, 2000
Researchers also determined that prophylactic isoniazid treatment of HIV-1 patients who have had TB reduces the chance that they will experience recurrence of the disease.
The study comprised 233 adult patients who had successfully completed six months of rifampicin treatment for active pulmonary tuberculosis. Of these, 142 were positive for HIV-1 and were randomized to receive either post-treatment isoniazid prophylaxis (n=68) for one year or placebo (n=74). The remaining 91 patients were not...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.